ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2024

Intranasal Multiepitope PD-L1-siRNA-Based Nanovaccine: The Next-Gen COVID-19 Immunotherapy.

Rita C Acúrcio et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.